Identification of Novel Prognostic Signatures for Clear Cell Renal Cell Carcinoma Based on ceRNA Network Construction and Immune Infiltration Analysis

OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) carries significant morbidity and mortality globally and is often resistant to conventional radiotherapy and chemotherapy. Immune checkpoint blockade (ICB) has received attention in ccRCC patients as a promising anticancer treatment. Furthermore, co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lu, Ye, Juan, Wen, Fengyun, Yu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938059/
https://www.ncbi.nlm.nih.gov/pubmed/35320950
http://dx.doi.org/10.1155/2022/4033583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8938059/
https://www.ncbi.nlm.nih.gov/pubmed/35320950
http://dx.doi.org/10.1155/2022/4033583

Ejemplares similares